NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients –– Acute unmet need in R/R ...
Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to ...
A 79-year-old man was admitted to a hospital in Guangzhou, China, with progressive dyspnea and edema. Echocardiography and ...
DISABLED ENTREPRENEUR UK on MSN
Understanding Paroxysmal Nocturnal Dyspnoea (PND) and Its Connection to Sleep Apnoea
Disclaimer: This article is for educational purposes only and does not replace medical advice. If you are experiencing ...
Johnson & Johnson (NYSE:JNJ) today announced the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) as a single agent treatment for adult patients ...
Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...
First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session ...
What happens when magnet fishing takes you to the strangest dumping ground ever? This adventure uncovered shocking finds that prove you never know what’s hiding underwater. Trump Warns of Threat to ...
Common causes of shortness of breath include physical deconditioning, obesity, anxiety, asthma, heart failure, heart attack, COPD, and pneumonia. However, feeling out of breath when walking short ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback